Klompas Neil A
President & COO at ZYME; Chief Operating Officer at Zymeworks Inc.
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 10, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ZYMEZymeworks Inc.President & COO
- Zymeworks Inc.Chief Operating Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Zymeworks Inc.37,712 shares
- ZYME2,977 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Zymeworks Inc.UnusualMay 6 2019
Sold 8,308 shares at $19.23 ($160k)
Klompas Neil A, Chief Financial Officer
Sold 51% of holdings ($313k position)7,977 shares leftFirst sale on recordFiling
- 2 Form 4 sale Zymeworks Inc.UnusualDec 9 +583 days
Sold 25,000 shares at $53.25 ($1.3M)
Klompas Neil A, Chief Financial Officer
Sold 73.3% of holdings ($1.8M position)9,122 shares leftFiling
- 3 Form 4 sale Zymeworks Inc.Plan not statedMar 10 +91 days
Sold 1,425 shares at $34.95 ($50k)
Klompas Neil A, Chief Financial Officer
Sold 12% of holdings ($416k position)10,471 shares leftFiling
- 4 Form 4 sale Zymeworks Inc.Plan not statedMar 10 +365 days
Sold 2,979 shares at $6.88 ($20k)
Klompas Neil A, Chief Operating Officer
Sold 18.3% of holdings ($112k position)13,276 shares leftFiling
- 5 Form 4 sale ZYMEPlan not statedMar 10 +365 days
Sold 2,977 shares at $7.83 ($23k)
Klompas Neil A, President & COO
Sold 14.9% of holdings ($157k position)17,032 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | ZYME | President & COO | Form 4 sale | 2,977 | $23k | 14.9% | Plan not stated | SEC |
| Mar 10, 2022 | Zymeworks Inc. | Chief Operating Officer | Form 4 sale | 2,979 | $20k | 18.3% | Plan not stated | SEC |
| Mar 10, 2021 | Zymeworks Inc. | Chief Financial Officer | Form 4 sale | 1,425 | $50k | 12.0% | Plan not stated | SEC |
| Dec 9, 2020 | Zymeworks Inc. | Chief Financial Officer | Form 4 sale | 25,000 | $1.3M | 73.3% | Unusual | SEC |
| May 6, 2019 | Zymeworks Inc. | Chief Financial Officer | Form 4 sale | 8,308 | $160k | 51.0% | Unusual | SEC |